Research product

Overview & Purchase

Review available strengths, current inventory, product details, approved COAs, and research-use information.

KPV - 10mg

Amino

KPV - 10mg

Also known as KLOW Blend, Quad Regenerative Stack, BPC + TB4 + Copper Peptide + KPV, Anti-Inflammatory Regeneration Quad, GLOW + KPV, KPV peptide, Lys-Pro-Val, Lysine-Proline-Valine

$41.25

In Stock

KPV - 10mg is a clearly identified research-use reference material supplied in the verified 10mg · 1 vial presentation. Verified product specification: 10mg. A current lot-specific Certificate of Analysis is available for quality and traceability documentation. Research Use Only. Not for human use. Not for animal use.

1
Research use only. Products are intended strictly for qualified laboratory or in-vitro research and are not for human or veterinary use.

COAs & testing

Current and historical batch documentation

Approved testing records for this product and selected strength are shown directly on the purchase page. Results apply only to the documented sample or batch.

Open COA library

Safety Data Sheet (SDS)

KPV

Revision 1.0 · August 30, 2026 · Formulation-level safety, handling, storage, first-aid, and transport information.

Download SDS

Historical COA

Lot LPR-KPV10-01

Laboratory
ILS Laboratories LLC
Report
COA-2026-KYMAJ0
Test date
2026-08-03
Issued
2026-08-03
Purity
99.61% purity
Assay
Peptide Purity (HPLC): 99.61%; Net Peptide Content: 10.46 mg; Identity (ID): Confirmed; Confirmed Fentanyl Free
Disposition
pass

Technical specifications

Compound information

Molecular, technical, storage, and laboratory-handling information for the selected variation. Unknown or unverified fields remain blank.

Molecular profile

Product
KPV - 10mg
Strength
Standard
Product form
simple
Canonical compound
KPV - 10mg
Alternate names
KLOW Blend, Quad Regenerative Stack, BPC + TB4 + Copper Peptide + KPV, Anti-Inflammatory Regeneration Quad, GLOW + KPV, KPV peptide, Lys-Pro-Val, Lysine-Proline-Valine
Blend components
KPV
PubChem CID
13294447
Molecular formula
C11H12O3
Molecular weight
192.21
IUPAC name
2-oxo-5-phenylpentanoic acid

Storage requirements

Storage
Refrigerate after mixing, 0°C–8°C. Keep away from UV light.

Source provenance

Technical fields retain their approved evidence category and linked source identifiers.

iupac name

public compound database

Sources: pubchem-10c7cd58582369e6

pubchem cid

public compound database

Sources: pubchem-10c7cd58582369e6

canonical name

public compound database

Sources: pubchem-10c7cd58582369e6

canonical smiles

public compound database

Sources: pubchem-10c7cd58582369e6

molecular weight

public compound database

Sources: pubchem-10c7cd58582369e6

molecular formula

public compound database

Sources: pubchem-10c7cd58582369e6

Storage and handling information is for laboratory operations only. It is not dosing, administration, or medical guidance, and it does not replace a lot-specific expiration or stability document.

Peer-reviewed research

The research behind this compound

Open complete compound profile

Journal studies

Research articles and study summaries

All articles

KPV: Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.

Airborne particulate matter (PM) poses a major environmental risk that impairs skin health by triggering oxidative stress, inflammation, and cell death. In this study, we investigated the protective effects of Lysine-Proline-Valine (KPV)-an endogenous peptide derived from α-melanocyte-stimulating hormone-against oxidative damage and inflammation induced by fine PM (PM 10 ) in human HaCaT keratinocytes. Our results show that PM 10 markedly suppresses HaCaT cell proliferation via cytotoxic effects and induces a pro-inflammatory response by increasing IL-1β secretion.

Read sourced summary

KPV: Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates.

A simple, sensitive and stability-indicating high-performance liquid chromatographic (HPLC) assay method was developed and validated for a bioactive peptide, lysine-proline-valine (KPV) in aqueous solutions and skin homogenates. Chromatographic separation was achieved on a reversed phase Phenomenex C18 column (4.6 × 250 mm, packed with 5 µm silica particles) with a gradient mobile phase consisting of 0.1% trifluoroacetic acid (TFA) in water (A) and 0.1% TFA in acetonitrile (B). The proposed HPLC method was validated with respect to accuracy, precision, linearity, repeatability, limit of detection (LOD) and limit of quantitation (LOQ).

Read sourced summary

KPV: Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.

Lysine-proline-valine (KPV) is a C-terminal peptide fragment of α-melanocyte stimulating hormone with potent anti-inflammatory properties. Present study investigates various transdermal enhancement strategies such as iontophoresis (ITP), microneedles (MN), and their combination (ITP + MN) on KPV delivery across dermatomed human skin. KPV attains a positive charge at pH less than 7.0, thus anodal ITP was used.

Read sourced summary

KPV: Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPARγ pathway in HepG2 cells.

Hepatocellular steatosis, an early stage within the non-alcoholic fatty liver disease (NAFLD) spectrum, is characterized by excessive lipid accumulation and oxidative stress in hepatocytes. This study examined the protective role of Lysine-Proline-Valine (KPV), an endogenous tripeptide derived from α-melanocyte-stimulating hormone, against oleic acid (OA)-induced oxidative damage and lipid accumulation in hepatic epithelial HepG2 cells. OA treatment markedly enhanced hepatic lipid deposition by upregulation of fatty acid synthase (FAS) expression.

Read sourced summary

KPV: Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.

In this study, we analyzed the anti-inflammatory effects of alpha-melanocyte stimulating hormone (MSH)11-13 (KPV) in comparison with other MSH peptides in a model of crystal-induced peritonitis. Systemic treatment of mice with KPV, alpha-MSH, the core melanocortin peptide His-Phe-Arg-Trp, and the melanocontin receptor 3/4 agonist Ac-Nle4-c[Asp5,d-Phe7,Lys10]NH2 ACTH4-10 (MTII) but not the selective MC1-R agonist H-Ser-Ser-Ile-Ile-Ser-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 (MS05) resulted in a significant reduction in accumulation of polymorphonuclear leukocyte in the peritoneal cavity. The antimigratory effect of KPV was not blocked by the MC3/4-R antagonist Ac-Nle4-c[Asp5,d-2Nal7,Lys10]NH2 ACTH4-10 (SHU9119).

Read sourced summary

KPV: Faculty Opinions recommendation of PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

This record is linked for reviewer verification. Open the source to confirm the study design, model, outcomes, and limitations before publication.

Read sourced summary

KPV: Structural modification of the tripeptide KPV by reductive “glycoalkylation” of the lysine residue

This record is linked for reviewer verification. Open the source to confirm the study design, model, outcomes, and limitations before publication.

Read sourced summary

KPV: C-terminal tripeptide KPV of α-MSH modulates the selectivity of melanotropins in the melanocortin system

The melanocortin system is essential for survival, with the melanocortin-3 and -4 receptors (hMC3R and hMC4R) regulating energy homeostasis and metabolism, and the melanocortin-1 receptor (hMC1R) controlling pigmentation and skin cancer prevention. However, achieving subtype selectivity among these receptors remains challenging due to their high sequence similarity. Here, we first systematically examined the impact of the α-MSH C-terminal tripeptide –Lys-Pro-Val (–KPV) on melanotropin conformation and receptor selectivity.

Read sourced summary
Educational summaries describe published research cautiously and do not make diagnostic, treatment, dosing, cure, or human-use claims. Human, animal, in-vitro, computational, and review evidence are identified separately. Registered trials are not the same as published results. Last reviewed: 2026-09-12T04:00:57.881+00:00.

Original sources

Sources, journals & trials

Third-party sources are linked for independent review. A citation does not imply endorsement of this store or product.

1. other · unknown

PubChem compound record for KPV

National Center for Biotechnology Information · PubChem

Structured public compound identifiers and computed chemical properties. Product-specific stability, purity, lot results, and shelf life are not inferred from this record.

Why linked: Official PubChem identity record returned for the resolved component KPV.

public compound database

2. pubmed · animal

Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.

Junghee Sung, Seo-Young Ju, SeungHyun Park, Won-Kyo Jung, Jae-Young Je, Sei-Jung Lee · Tissue & cell · 2025

Airborne particulate matter (PM) poses a major environmental risk that impairs skin health by triggering oxidative stress, inflammation, and cell death. In this study, we investigated the protective effects of Lysine-Proline-Valine (KPV)-an endogenous peptide derived from α-melanocyte-stimulating hormone-against oxidative damage and inflammation induced by fine PM (PM 10 ) in human HaCaT keratinocytes. Our results show that PM 10 markedly suppresses HaCaT cell proliferation via cytotoxic effects and induces a pro-inflammatory response by increasing IL-1β secretion. Notably, treatment with 50 μg/mL of KPV restored cell viability and reduced IL-1β secretion disrupted by PM 10 exposure. To counteract PM 10 -induced cell death, KPV inhibited reactive oxygen species (ROS) production, which is responsible for activating extracellular signal-regulated kinase and p

Why linked: The title contains the resolved identity “Lysine-Proline-Valine”.

3. pubmed · animal

Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates.

Kasturi R Pawar, Vanisree Mulabagal, Forrest Smith, Chandra S Kolli, Vijaya K Rangari, R Jayachandra Babu · Biomedical chromatography : BMC · 2016

A simple, sensitive and stability-indicating high-performance liquid chromatographic (HPLC) assay method was developed and validated for a bioactive peptide, lysine-proline-valine (KPV) in aqueous solutions and skin homogenates. Chromatographic separation was achieved on a reversed phase Phenomenex C18 column (4.6 &#xd7; 250 mm, packed with 5 &#xb5;m silica particles) with a gradient mobile phase consisting of 0.1% trifluoroacetic acid (TFA) in water (A) and 0.1% TFA in acetonitrile (B). The proposed HPLC method was validated with respect to accuracy, precision, linearity, repeatability, limit of detection (LOD) and limit of quantitation (LOQ). The calibration curve was linear with a correlation coefficient (r) of 0.9999. Relative standard deviation values of accuracy and precision experiments were <2. The LOD and LOQ of KPV were 0.01 and 0.25 &#xb5;g/mL, respectively. Under stress condi

Why linked: The title contains the resolved identity “KPV”.

DOI 10.1002/bmc.3347PMID 25298219Evaluation Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.

4. pubmed · animal

Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.

Kasturi Pawar, Chandra S Kolli, Vijaya K Rangari, R Jayachandra Babu · Journal of pharmaceutical sciences · 2018

Lysine-proline-valine (KPV) is a C-terminal peptide fragment of &#x3b1;-melanocyte stimulating hormone with potent anti-inflammatory properties. Present study investigates various transdermal enhancement strategies such as iontophoresis (ITP), microneedles (MN), and their combination (ITP&#xa0;+ MN) on KPV delivery across dermatomed human skin. KPV attains a positive charge at pH less than 7.0, thus anodal ITP was used. The influence of current strength, KPV concentration, and duration of current application on the KPV delivery was investigated. At defined ITP parameters, the influence of MN on KPV delivery (ITP&#xa0;+ MN) across skin was also determined. KPV permeation was less than detectable levels (limit of detection, 0.01 &#x3bc;g/mL) by simple passive diffusion. However, KPV permeation was increased to 4.4 &#x3bc;g/cm 2 /h by MN treatment. Furthermore, ITP and ITP&#xa0;+ MN increas

Why linked: The title contains the resolved identity “KPV”.

DOI 10.1016/j.xphs.2017.03.017PMID 28343991Journal Article, Research Support, U.S. Gov't, Non-P.H.S.

5. pubmed · animal

Lysine-proline-valine peptide attenuates hepatic lipid accumulation through ROS-dependent regulation of the PPAR&#x3b3; pathway in HepG2 cells.

Ju-Yeon Lee, Jin Lee, Won-Kyo Jung, Jae-Young Je, Sei-Jung Lee · Cytotechnology · 2026

Hepatocellular steatosis, an early stage within the non-alcoholic fatty liver disease (NAFLD) spectrum, is characterized by excessive lipid accumulation and oxidative stress in hepatocytes. This study examined the protective role of Lysine-Proline-Valine (KPV), an endogenous tripeptide derived from &#x3b1;-melanocyte-stimulating hormone, against oleic acid (OA)-induced oxidative damage and lipid accumulation in hepatic epithelial HepG2 cells. OA treatment markedly enhanced hepatic lipid deposition by upregulation of fatty acid synthase (FAS) expression. Treatment with KPV (100&#xa0;&#xb5;g/mL) significantly attenuated OA-induced lipid accumulation and suppressed FAS expression without inducing cytotoxicity. Mechanistic analysis revealed that KPV reduced reactive oxygen species generation, thereby preventing activation of extracellular signal-regulated kinase. KPV also downregulated AKT p

Why linked: The title contains the resolved identity “Lysine-Proline-Valine”.

6. pubmed · animal

Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides.

Stephen J Getting, Helgi B Schi&#xf6;th, Mauro Perretti · The Journal of pharmacology and experimental therapeutics · 2003

In this study, we analyzed the anti-inflammatory effects of alpha-melanocyte stimulating hormone (MSH)11-13 (KPV) in comparison with other MSH peptides in a model of crystal-induced peritonitis. Systemic treatment of mice with KPV, alpha-MSH, the core melanocortin peptide His-Phe-Arg-Trp, and the melanocontin receptor 3/4 agonist Ac-Nle4-c[Asp5,d-Phe7,Lys10]NH2 ACTH4-10 (MTII) but not the selective MC1-R agonist H-Ser-Ser-Ile-Ile-Ser-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 (MS05) resulted in a significant reduction in accumulation of polymorphonuclear leukocyte in the peritoneal cavity. The antimigratory effect of KPV was not blocked by the MC3/4-R antagonist Ac-Nle4-c[Asp5,d-2Nal7,Lys10]NH2 ACTH4-10 (SHU9119). In vitro, macrophage activation, determined as release of KC and interleukin (IL)-1beta was inhibited by alpha-MSH and MTII but not by KPV. Furthermore, macrophage activation by MTII

Why linked: The title contains the resolved identity “KPV”.

DOI 10.1124/jpet.103.051623PMID 12750433Journal Article, Research Support, Non-U.S. Gov't

7. crossref · animal

Faculty Opinions recommendation of PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.

Helen Raybould · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2008

Why linked: The title contains the resolved identity “KPV”.

8. crossref · unknown

Structural modification of the tripeptide KPV by reductive “glycoalkylation” of the lysine residue

Abigael C. Songok, Pradip Panta, William T. Doerrler, Megan A. Macnaughtan, Carol M. Taylor · PLOS ONE · 2018

Why linked: The title contains the resolved identity “KPV”.

9. crossref · animal

C-terminal tripeptide KPV of α-MSH modulates the selectivity of melanotropins in the melanocortin system

Joel B. Nyberg, Adrian Drake De la Peña, Jennifer Bao, Victor J. Hruby, Minying Cai · Australian Journal of Chemistry · 2025

The melanocortin system is essential for survival, with the melanocortin-3 and -4 receptors (hMC3R and hMC4R) regulating energy homeostasis and metabolism, and the melanocortin-1 receptor (hMC1R) controlling pigmentation and skin cancer prevention. However, achieving subtype selectivity among these receptors remains challenging due to their high sequence similarity. Here, we first systematically examined the impact of the α-MSH C-terminal tripeptide –Lys-Pro-Val (–KPV) on melanotropin conformation and receptor selectivity. Incorporation of –KPV enhanced binding affinity toward hMCRs and modulated receptor preference. We identified a selective hMC3R antagonist, peptide 5 ([CO(CH₂)₂CO-DNal(2′)-Arg-Trp-Lys]-Gly-Lys-Pro-Val-NH₂) and a selective hMC3R agonist, peptide 20 (H-DNal(2′)-c[Asp-Pro-DPhe-Arg-Trp-Lys]-Ala-Gly-Pro-Val-NH₂). Additionally, several hMC1R-selective agonists (peptides 9–11

Why linked: The title contains the resolved identity “KPV”.

DOI 10.1071/ch25144journal-article

10. crossref · unknown

PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation

Guillaume Dalmasso, Laetitia Charrier–Hisamuddin, Hang Thi Thu Nguyen, Yutao Yan, Shanthi Sitaraman, Didier Merlin · Gastroenterology · 2008

Why linked: The title contains the resolved identity “KPV”.

11. crossref · unknown

III. Die Tafel der Kategorien der Freiheit (KpV A 117)

Kants "Kategorien der Freiheit" · 2011

Why linked: The title contains the resolved identity “KPV”.

12. crossref · unknown

PepT1 mediated tripeptide KPV uptake reduces intestinal inflammation

G Dalmasso, L Charrier-Hisamuddin, H Nguyen, Y Yan, S Sitaraman, D Merlin · Inflammatory Bowel Diseases · 2008

Why linked: The title contains the resolved identity “KPV”.

Shipping & returns

Shipping

Processing windows, service levels, tracking, destination restrictions, and fees are provided by Evia during checkout and on the full shipping page.

Read shipping policy

Returns & replacements

Eligibility, damage claims, replacement evidence, exclusions, and reporting windows are defined by the store’s published policy.

Read returns policy

Product FAQ

How do I select the correct Strength?

Use the variation selector on the Overview & Purchase page. The selected option controls price, availability, lot context, and applicable COAs.

Where can I find current testing documentation?

Open COAs & Testing. Only approved public documents associated with the product or selected variation are displayed.

Is this product intended for human use?

No. Storefront products are offered strictly for qualified laboratory or in-vitro research and are not for human or veterinary use.

How quickly are orders processed?

Order timing is shown during checkout and shipment updates are provided automatically.

How can I contact support?

Use the support email shown on this storefront and the store team will help.